Targeting the LHX1-LDB1 Complex Restores STING-dependent Senescence Surveillance and Inhibits Head and Neck Cancer Progression
Abstract
restored STING-dependent SASP and impaired cancer stem cell self-renewal. Therapeutic disruption of the LHX1-LDB1 complex using engineered peptides re-activated STING signaling, induced SASP, and significantly suppressed tumor growth. In this study, we employed human and mouse-derived HNSCC cell lines, xenograft models, and clinical samples to assess the functional relevance of LHX1 in regulating SASP and tumor progression. Our findings reveal LHX1 as a master transcriptional repressor of STING-mediated senescence and highlight the therapeutic potential of targeting the LHX1-LDB1 axis to restore tumor-suppressive SASP in HNSCC.
Fields of Study & Subjects
interferon and immune responses
Protein Degradation and Inhibitors
Chromatin Remodeling and Cancer
Publication details
- Journal / source
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Volume
- 22
- Issue
- 3
- Pages
- 1186–1206
- Publication date
- 1 January 2026
- Language
- EN